ArticleRevista de la Facultad de Ciencias Medicas (Cordoba, Argentina)2025
[Anaemia and heart failure with preserved ejection fraction in adult patients with cardiorenal syndrome: a cross-sectional study]
Article in Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study addres the issue of anemia in patients with acute decompensated heart failure and chronik kidney disease, affering a valuable contribution due to its multicenter desing and the clinical relevance of the topic. Hawever, it is presents sinificant methodological limitations, sucha sa, the absence of a clearly stated hypotesis, the exclution of the sugrups with mid-range ejection fraction, limited justification of the multivariable models, and the dichotomization of hemoglobin, which may have compromised the sensibility of the analysis. Moreover, key clinical variables sucha s comorbidities, volume status, or inflamatory markers were not included. From a clinical and epidemiological prespective, the estudy confirms the high prevalence of anemia in this setting, particularly in patients with renal dysfunction and preserved ejection fraction, where it exceeds 40% and is associated with a worse prognosis. Hemoglobin may act as a mediator between the decline in renal function and functional capacity. A better understanding of these mechanisms requires more robust statistical models and more precise clinical characterization to guide more effective interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.